JP2021518365A5 - - Google Patents
Info
- Publication number
- JP2021518365A5 JP2021518365A5 JP2020549702A JP2020549702A JP2021518365A5 JP 2021518365 A5 JP2021518365 A5 JP 2021518365A5 JP 2020549702 A JP2020549702 A JP 2020549702A JP 2020549702 A JP2020549702 A JP 2020549702A JP 2021518365 A5 JP2021518365 A5 JP 2021518365A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- genome
- expression cassette
- derived
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024047652A JP2024073654A (ja) | 2018-03-16 | 2024-03-25 | 神経栄養因子の誘導可能な発現のための方法及び組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862644332P | 2018-03-16 | 2018-03-16 | |
| US62/644,332 | 2018-03-16 | ||
| US201862773752P | 2018-11-30 | 2018-11-30 | |
| US62/773,752 | 2018-11-30 | ||
| PCT/US2019/022595 WO2019178550A1 (en) | 2018-03-16 | 2019-03-15 | Methods and compositions for inducible expression of neurotrophic factors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024047652A Division JP2024073654A (ja) | 2018-03-16 | 2024-03-25 | 神経栄養因子の誘導可能な発現のための方法及び組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021518365A JP2021518365A (ja) | 2021-08-02 |
| JP2021518365A5 true JP2021518365A5 (https=) | 2022-02-17 |
| JP7535944B2 JP7535944B2 (ja) | 2024-08-19 |
Family
ID=67907321
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020549702A Active JP7535944B2 (ja) | 2018-03-16 | 2019-03-15 | 神経栄養因子の誘導可能な発現のための方法及び組成物 |
| JP2024047652A Pending JP2024073654A (ja) | 2018-03-16 | 2024-03-25 | 神経栄養因子の誘導可能な発現のための方法及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024047652A Pending JP2024073654A (ja) | 2018-03-16 | 2024-03-25 | 神経栄養因子の誘導可能な発現のための方法及び組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12258571B2 (https=) |
| EP (1) | EP3765058A4 (https=) |
| JP (2) | JP7535944B2 (https=) |
| KR (1) | KR102843346B1 (https=) |
| CN (1) | CN111867617A (https=) |
| AU (1) | AU2019236288B2 (https=) |
| WO (1) | WO2019178550A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190018000A1 (en) | 2016-01-12 | 2019-01-17 | Cedars-Sinai Medical Center | A method of non destructive monitoring of biological processes in microfluidic tissue culture systems |
| JP2019511243A (ja) | 2016-01-26 | 2019-04-25 | シーダーズ−サイナイ メディカル センター | インビボのデュアルリコンビナーゼ媒介性カセット交換（ｄＲＭＣＥ）のためのシステム及び方法ならびにその疾患モデル |
| US11913022B2 (en) | 2017-01-25 | 2024-02-27 | Cedars-Sinai Medical Center | In vitro induction of mammary-like differentiation from human pluripotent stem cells |
| US11767513B2 (en) | 2017-03-14 | 2023-09-26 | Cedars-Sinai Medical Center | Neuromuscular junction |
| WO2018176001A2 (en) | 2017-03-24 | 2018-09-27 | Cedars-Sinai Medical Center | Methods and compositions for production of fallopian tube epithelium |
| US12258571B2 (en) | 2018-03-16 | 2025-03-25 | Cedars-Sinai Medical Center | Methods and compositions for inducible expression of neurotrophic factors |
| EP4700387A2 (en) | 2018-03-23 | 2026-02-25 | Cedars-Sinai Medical Center | Methods of use of islet cells |
| WO2019195800A1 (en) | 2018-04-06 | 2019-10-10 | Cedars-Sinai Medical Center | Novel differentiation technique to generate dopaminergic neurons from induced pluripotent stem cells |
| WO2019195798A1 (en) | 2018-04-06 | 2019-10-10 | Cedars-Sinai Medical Center | Human pluripotent stem cell derived neurodegenerative disease models on a microfluidic chip |
| EP3787613B1 (en) | 2018-04-30 | 2026-03-11 | Cedars-Sinai Medical Center | Pkc activation for use in treating early onset sporadic parkinson's disease |
| WO2020084168A1 (en) * | 2018-10-26 | 2020-04-30 | Icm (Institut Du Cerveau Et De La Moelle Épinière) | Tetracycline compound for treating drug-induced dyskinesia |
| CA3158428A1 (en) * | 2019-10-22 | 2021-04-29 | Cedars-Sinai Medical Center | Cortical neural progenitor cells from ipscs |
| US20230047254A1 (en) * | 2019-12-29 | 2023-02-16 | Gloriana Therapeutics | Mammalian Cells Secreting GDNF and Their Therapeutic Use |
| KR20220061403A (ko) * | 2020-11-06 | 2022-05-13 | (주) 에스바이오메딕스 | 다능성 줄기세포 유래 신경전구세포를 포함하는 퇴행성 뇌질환 치료용 약학적 조성물 |
| CN121420065A (zh) * | 2023-06-29 | 2026-01-27 | 香港大学 | 用于在肝脏或肝癌中的可控转录的方法 |
| GB202312699D0 (en) * | 2023-08-18 | 2023-10-04 | Cambridge Entpr Ltd | Controllable expression in mammalian cells |
| WO2025091023A1 (en) * | 2023-10-27 | 2025-05-01 | Northwestern University | Engineered cell transfected by all-in-one vector for therapeutic agents production and delivery and applications thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7575924B2 (en) | 2000-11-13 | 2009-08-18 | Research Development Foundation | Methods and compositions relating to improved lentiviral vectors and their applications |
| WO2003020743A1 (en) | 2001-09-05 | 2003-03-13 | Regeneron Pharmaceuticals, Inc. | Methods of expressing transgenes |
| CA2484223A1 (en) | 2002-04-25 | 2003-11-06 | Wisconsin Alumni Research Foundation | Use of human neural stem cells secreting gdnf for treatment of parkinson's and other neurodegenerative diseases |
| GB2404382B (en) | 2003-07-28 | 2008-01-30 | Oxitec Ltd | Pest control |
| US20120107284A1 (en) * | 2006-06-30 | 2012-05-03 | Elena Kozlova | Stem cells for transplantation and methods for production thereof |
| WO2008079608A1 (en) | 2006-12-21 | 2008-07-03 | Genentech, Inc. | Compositions and methods for the expression of nucleic acids |
| US8592211B2 (en) * | 2009-03-20 | 2013-11-26 | The Rockefeller University | Enhanced PiggyBac transposon and methods for transposon mutagenesis |
| US20120107938A1 (en) | 2009-06-29 | 2012-05-03 | University Of Basel | Methods and kits for high efficiency engineering of conditional mouse alleles |
| WO2013155222A2 (en) | 2012-04-10 | 2013-10-17 | The Regents Of The University Of California | Brain-specific enhancers for cell-based therapy |
| CN102816793B (zh) * | 2012-08-22 | 2014-09-10 | 陕西师范大学 | 单载体双向启动的Tet-on诱导表达系统及其构建方法和应用 |
| WO2014127289A1 (en) * | 2013-02-15 | 2014-08-21 | International Stem Cell Corporation | Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases |
| JP6473077B2 (ja) * | 2013-03-21 | 2019-02-20 | 国立大学法人京都大学 | 神経分化誘導用の多能性幹細胞 |
| WO2014204724A1 (en) | 2013-06-17 | 2014-12-24 | The Broad Institute Inc. | Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation |
| ES2939807T3 (es) | 2014-03-21 | 2023-04-27 | Fujifilm Cellular Dynamics Inc | Producción de neuronas dopaminérgicas del mesencéfalo y métodos para su utilización |
| AU2015234242B2 (en) * | 2014-03-21 | 2020-09-24 | Children's Medical Research Institute | Stable gene transfer to proliferating cells |
| US20170274048A1 (en) | 2014-03-28 | 2017-09-28 | Buck Institute For Research On Aging | Methods and compositions for modulating the imune system |
| EP3584312A1 (en) | 2014-06-27 | 2019-12-25 | Angiocrine Bioscience, Inc. | Neural cells expressing adenovirus e4orf1, and methods of making and using the same |
| KR20250141836A (ko) | 2015-11-04 | 2025-09-29 | 페이트 세러퓨틱스, 인코포레이티드 | 만능 세포의 유전자 조작 |
| JP2019511243A (ja) | 2016-01-26 | 2019-04-25 | シーダーズ−サイナイ メディカル センター | インビボのデュアルリコンビナーゼ媒介性カセット交換（ｄＲＭＣＥ）のためのシステム及び方法ならびにその疾患モデル |
| US10221395B2 (en) | 2016-06-16 | 2019-03-05 | Cedars-Sinai Medical Center | Efficient method for reprogramming blood to induced pluripotent stem cells |
| US12258571B2 (en) | 2018-03-16 | 2025-03-25 | Cedars-Sinai Medical Center | Methods and compositions for inducible expression of neurotrophic factors |
| CA3143981A1 (en) | 2019-06-17 | 2020-12-24 | Cedars-Sinai Medical Center | Systems and methods for in vivo dual recombinase-mediated cassette exchange (drmce) and disease models thereof |
-
2019
- 2019-03-15 US US16/979,640 patent/US12258571B2/en active Active
- 2019-03-15 AU AU2019236288A patent/AU2019236288B2/en active Active
- 2019-03-15 WO PCT/US2019/022595 patent/WO2019178550A1/en not_active Ceased
- 2019-03-15 KR KR1020207029729A patent/KR102843346B1/ko active Active
- 2019-03-15 EP EP19768063.0A patent/EP3765058A4/en active Pending
- 2019-03-15 JP JP2020549702A patent/JP7535944B2/ja active Active
- 2019-03-15 CN CN201980019683.6A patent/CN111867617A/zh active Pending
-
2024
- 2024-03-25 JP JP2024047652A patent/JP2024073654A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021518365A5 (https=) | ||
| JP2024073654A5 (https=) | ||
| Jiang et al. | Role of a VGF/BDNF/TrkB autoregulatory feedback loop in rapid-acting antidepressant efficacy | |
| Park et al. | Human neural stem cells over-expressing choline acetyltransferase restore cognition in rat model of cognitive dysfunction | |
| Dirren et al. | SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice | |
| US10907138B2 (en) | TATk-CDKL5 fusion proteins, compositions, formulations, and use thereof | |
| Lee et al. | miR-381 attenuates peripheral neuropathic phenotype caused by overexpression of PMP22 | |
| Perego et al. | Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1) | |
| KR101749138B1 (ko) | 신경질환 예방 또는 치료를 위한 aimp2-dx2를 포함하는 약학 조성물 및 이의 용도 | |
| US9486540B2 (en) | Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat central nervous system disorders | |
| KR20240110849A (ko) | Aadc/gdnf 폴리뉴클레오티드 및 이의 파킨슨병 치료에 있어서의 용도 | |
| EP3754025A1 (en) | Mesenchymal stem cells expressing brain-derived neurotrophic factor and use thereof | |
| Zhu et al. | Neuroprotective effects of human umbilical cord-derived mesenchymal stem cells from different donors on spinal cord injury in mice | |
| Jiang et al. | Gene therapy using human FMRP isoforms driven by the human FMR1 promoter rescues fragile X syndrome mouse deficits | |
| EP3119406B1 (en) | Methods for improving cognitive function via modulation of quinone reductase 2 | |
| CA3085576A1 (en) | Peptides and other agents for treating pain and increasing pain sensitivity | |
| Sharma | Innovative genoceuticals in human gene therapy solutions: challenges and safe clinical trials of orphan gene therapy products | |
| US10220077B2 (en) | Combination treatment for amyotrophic lateral sclerosis (ALS) | |
| Lin et al. | Exercise alleviates cognitive dysfunction in Alzheimer’s disease mice via skeletal muscle-derived extracellular vesicles that enhance plaque clearance by microglia | |
| Wang et al. | Viral vectors in neurodegenerative diseases: immune responses and therapeutic applications | |
| Ye et al. | Peptide OM-LV20 demonstrates neuroprotective effects by attenuating mitochondria-mediated neuronal apoptosis and dysfunction in mice with traumatic brain injury. | |
| KR20250047689A (ko) | 알파-시누클레인 응집 억제용 조성물 및 응집억제 방법 | |
| Crippa | Exploiting GDNF as a potential target for neuroprotective therapy in neurodegenerative diseases | |
| Duba-Kiss | Developing AAV Gene Therapy Tools for Neurodevelopmental Epileptic Encephalopathies | |
| Fol et al. | 59. APPsα Gene Therapy for Alzheimer's Disease |